ECYT

Endocyte, Inc. Common Stock
ECYT

Delisted

ECYT was delisted on the 20th of December, 2018.

Back to rankings

2 hedge funds and large institutions have $1.45M invested in Endocyte, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 139 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.44M

Top Sellers

1
-$110M
2
-$94.2M
3
-$93.7M
4
VMI
VHCP Management II
New York
-$74.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$62.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
126
Citigroup
New York
–
DWA
127
Dorsey Wright & Associates
California
–
GAM
128
Gemmer Asset Management
California
–
WSTAM
129
Wilbanks Smith & Thomas Asset Management
Virginia
–
LTFS
130
Ladenburg Thalmann Financial Services
Florida
–
ClearBridge Investments
131
ClearBridge Investments
New York
–
SWM
132
SeaCrest Wealth Management
New York
–
KF
133
Krilogy Financial
Missouri
–
FANJ
134
Financial Architects (New Jersey)
New Jersey
–
CSS
135
Cubist Systematic Strategies
Connecticut
–
Bank of Montreal
136
Bank of Montreal
Ontario, Canada
–
Nisa Investment Advisors
137
Nisa Investment Advisors
Missouri
–
Daiwa Securities Group
138
Daiwa Securities Group
Japan
–
CTC
139
Central Trust Company
Missouri
–
WAS
140
WESPAC Advisors SoCal
California
–
FFC
141
First Financial Corp
Indiana
–
MIM
142
Monashee Investment Management
Massachusetts
–
2 3 4 5
6